Workflow
Janux Therapeutics (JANX) Investor Presentation - Slideshow

Developing Tumor Activated T Cell Therapeutics May 2022 2 Forward-looking statements and disclaimers This presentation includes certain forward-looking statements that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements regarding Janux Therapeutics, Inc. (the "Company"). These forward-looking statement include, but are not limited to, those regarding the Company's ...